NCT00484497
- Conditions
- Dyssomnias, Insomnia, Mental Disorders, +4 more
- Locations
-
- Clinical Research Center- Hopital Cardiologique Lyon, France
Clinical trial condition
Dyssomnias
Explore clinical trials studying Dyssomnias. Study availability and eligibility vary by location and protocol.
4,916 public trials
733 recruiting studies
Dyssomnias trial results
NCT00479284
- Conditions
- Apnea, Chronic Disease, Chronic Hypercapnic Respiratory Failure, +23 more
- Locations
-
- Sleep Laboratory; Department of Psychiatry, Geneva University Hospital Chêne-Bourg, Canton of Geneva, Switzerland
NCT00477828
- Conditions
- Apnea, Brain Diseases, Central Nervous System Diseases, +12 more
- Locations
-
- University of California San Diego San Diego, California, United States
NCT00381199
- Conditions
- Chronic Pain, Dyssomnias, Fibromyalgia, +13 more
- Locations
-
- McGill University Health Centre, Pain Centre Montreal, Quebec, Canada
NCT00287391
- Conditions
- Deglutition Disorders, Digestive System Diseases, Dyssomnias, +12 more
- Locations
-
- UNC Gastroenterology and UNC Sleep Disorders Center Chapel Hill, North Carolina, United States
Completed
Effects of Ramelteon on Driving Ability
NCT00319215
- Conditions
- Dyssomnias, Insomnia, Mental Disorders, +4 more
- Locations
-
- Utrecht Institute for Pharmaceutical Sciences Utrecht, Netherlands
NCT00127348
- Conditions
- Apnea, Cardiovascular Diseases, Dyssomnias, +9 more
- Locations
-
- Hospital Univ Arnau de Vilanova Lleida, Catalonia, Spain
Completed
A Study of Gaboxadol in Primary Insomnia
NCT00209846
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Non-US study, principal location: Gothenburg, Sweden
Completed
A Study of Gaboxadol in Primary Insomnia
NCT00209963
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
Not specified
Completed
A Study of Gaboxadol in Primary Insomnia
NCT00209924
- Conditions
- Dyssomnias, Mental Disorders, Nervous System Diseases, +4 more
- Locations
-
- Non-US study, principal location: Gothenburg, Sweden